Hellenic Institute for the Study of Sepsis Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: Athens Greece (2021)

Organization Overview

First Clinical Trial
2021
NCT02643654
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Hellenic Institute for the Study of Sepsis